Liam Ratcliffe
Director/Board Member at DISC MEDICINE, INC.
Net worth: - $ as of 2024-04-29
Network origin in Liam Ratcliffe first degree
Entity | Entity type | Industry | |
---|---|---|---|
362
| Public Company | Pharmaceuticals: Major | 362 |
University of Michigan
201
| College/University | Other Consumer Services | 201 |
University of Cape Town
88
| College/University | Other Consumer Services | 88 |
Public Company | Biotechnology | 22 | |
Public Company | Biotechnology | 19 | |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
16
| Extinct | Biotechnology | 16 |
Public Company | Biotechnology | 15 | |
Public Company | Biotechnology | 14 | |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA.
12
| Subsidiary | Biotechnology | 12 |
Public Company | Biotechnology | 10 | |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT.
9
| Subsidiary | Biotechnology | 9 |
Subsidiary | Pharmaceuticals: Major | 8 | |
Karus Therapeutics Ltd.
Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom.
7
| Holding Company | Biotechnology | 7 |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Jamanda Ltd.
Jamanda Ltd. Financial ConglomeratesFinance Jamanda Ltd. is an investment holding British company founded in 2016. The private company is based in Grantham, UK. The company's main function is to hold investments.
6
| Private Company | Financial Conglomerates | 6 |
Public Company | Biotechnology | 6 | |
Access Industries LLC
5
| Subsidiary | 5 | |
Halda Therapeutics LLC
Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT.
4
| Holding Company | Medical/Nursing Services | 4 |
4
| Public Company | Pharmaceuticals: Major | 4 |
Halda Therapeutics OpCo, Inc.
3
| Subsidiary | 3 | |
Public Company | Biotechnology | 3 | |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Liam Ratcliffe via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal President | |
Rochester Christian University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
CLAL INDUSTRIES LTD | Investment Managers | Director/Board Member Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor Director of Finance/CFO Corporate Officer/Principal | |
WMG Acquisition Corp.
WMG Acquisition Corp. Movies/EntertainmentConsumer Services WMG Acquisition Corp. engages in recording and publishing of music. It operates through two businesses: Recorded Music and Music Publishing. The Recorded Music business engages in marketing, sale and licensing of recorded music in various physical format such as CDs, LPs and DVDs, and digital format such as downloads, streaming and ringtones. The Music Publishing business owns and acquires rights to musical compositions, exploits and markets these compositions. The company was founded on March 18, 2004 and is headquartered in New York, NY. | Movies/Entertainment | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
University of Virginia | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Director/Board Member Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
University of British Columbia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Access Industries, Inc. (New York)
Access Industries, Inc. (New York) Investment ManagersFinance Access Industries, Inc (Access Industries) is a private equity/venture capital firm founded in 1986 by Len Blavatnik. The firm is headquartered in New York. | Investment Managers | Founder Chief Executive Officer Chairman | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ARCA BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
WARNER MUSIC GROUP CORP. | Commercial Printing/Forms | Director/Board Member Director/Board Member Director/Board Member | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
Georgetown University | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Harvard Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
The State University of New York | College/University | Undergraduate Degree Corporate Officer/Principal | |
Kent State University (Ohio) | College/University | Undergraduate Degree Masters Business Admin | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
The University of Connecticut School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Statistics
International
United States | 44 |
United Kingdom | 3 |
Israel | 2 |
China | 2 |
Canada | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 21 |
Finance | 7 |
Commercial Services | 4 |
Health Services | 2 |
Operational
Director/Board Member | 756 |
Corporate Officer/Principal | 251 |
Independent Dir/Board Member | 233 |
Chairman | 124 |
Undergraduate Degree | 88 |
Most connected contacts
Insiders | |
---|---|
James Healy | 50 |
Jeffrey Kindler | 48 |
Leslie Norwalk | 46 |
Stephen P. Squinto | 40 |
Kevin Bitterman | 36 |
Henry McKinnell | 35 |
Georges Gemayel | 33 |
Kush Parmar | 32 |
Anders Hove | 31 |
Kate Bingham | 31 |
Peter Corr | 28 |
Timothy Shannon | 28 |
Len Blavatnik | 28 |
Briggs Morrison | 26 |
Dennis Ausiello | 26 |
- Stock Market
- Insiders
- Liam Ratcliffe
- Company connections